// September 21, 2023
Beyond TB medicines: How quality assurance is elevating health systems in Central Asia
In Central Asia and Eastern Europe, multidrug-resistant tuberculosis (MDR-TB) accounts for a sign
In Central Asia and Eastern Europe, multidrug-resistant tuberculosis (MDR-TB) accounts for a sign
USP’s supplier qualification standard became official on Aug.
The development of generic versions of innovator medicines is a global public health need.
The issue of addressing potential nitrosamine impurities in medicines has been the focus at event